Reuters: FDA panel backs Amgen drug for blood disorder

[NaDiNe]

FDA panel backs Amgen drug for blood disorder
      

GAITHERSBURG, Maryland (Reuters) - A U.S. advisory panel unanimously urged regulators Wednesday to approve an Amgen drug for a rare blood disorder that puts patients at risk of serious bleeding.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login